IBDEI0W8 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32422,2)
 ;;=^5002396
 ;;^UTILITY(U,$J,358.3,32423,0)
 ;;=D58.2^^119^1564^83
 ;;^UTILITY(U,$J,358.3,32423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32423,1,3,0)
 ;;=3^Hemoglobinopathies,Other
 ;;^UTILITY(U,$J,358.3,32423,1,4,0)
 ;;=4^D58.2
 ;;^UTILITY(U,$J,358.3,32423,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,32424,0)
 ;;=C88.8^^119^1564^103
 ;;^UTILITY(U,$J,358.3,32424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32424,1,3,0)
 ;;=3^Malig Immunoproliferative Diseases,Other
 ;;^UTILITY(U,$J,358.3,32424,1,4,0)
 ;;=4^C88.8
 ;;^UTILITY(U,$J,358.3,32424,2)
 ;;=^5001750
 ;;^UTILITY(U,$J,358.3,32425,0)
 ;;=D70.8^^119^1564^174
 ;;^UTILITY(U,$J,358.3,32425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32425,1,3,0)
 ;;=3^Neutropenia,Other
 ;;^UTILITY(U,$J,358.3,32425,1,4,0)
 ;;=4^D70.8
 ;;^UTILITY(U,$J,358.3,32425,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,32426,0)
 ;;=D59.4^^119^1564^175
 ;;^UTILITY(U,$J,358.3,32426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32426,1,3,0)
 ;;=3^Nonautoimmune Hemolytic Anemias,Other
 ;;^UTILITY(U,$J,358.3,32426,1,4,0)
 ;;=4^D59.4
 ;;^UTILITY(U,$J,358.3,32426,2)
 ;;=^5002326
 ;;^UTILITY(U,$J,358.3,32427,0)
 ;;=D69.59^^119^1564^181
 ;;^UTILITY(U,$J,358.3,32427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32427,1,3,0)
 ;;=3^Secondary Thrombocytopenia,Other
 ;;^UTILITY(U,$J,358.3,32427,1,4,0)
 ;;=4^D69.59
 ;;^UTILITY(U,$J,358.3,32427,2)
 ;;=^5002369
 ;;^UTILITY(U,$J,358.3,32428,0)
 ;;=C22.7^^119^1564^46
 ;;^UTILITY(U,$J,358.3,32428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32428,1,3,0)
 ;;=3^Carcinomas of Liver,Other Spec
 ;;^UTILITY(U,$J,358.3,32428,1,4,0)
 ;;=4^C22.7
 ;;^UTILITY(U,$J,358.3,32428,2)
 ;;=^5000938
 ;;^UTILITY(U,$J,358.3,32429,0)
 ;;=D75.89^^119^1564^56
 ;;^UTILITY(U,$J,358.3,32429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32429,1,3,0)
 ;;=3^Diseases of Blood/Blood-Forming Organs,Other Spec
 ;;^UTILITY(U,$J,358.3,32429,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,32429,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,32430,0)
 ;;=D47.Z9^^119^1564^173
 ;;^UTILITY(U,$J,358.3,32430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32430,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,32430,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,32430,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,32431,0)
 ;;=D05.82^^119^1564^34
 ;;^UTILITY(U,$J,358.3,32431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32431,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,32431,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,32431,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,32432,0)
 ;;=D05.81^^119^1564^36
 ;;^UTILITY(U,$J,358.3,32432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32432,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,32432,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,32432,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,32433,0)
 ;;=D05.80^^119^1564^38
 ;;^UTILITY(U,$J,358.3,32433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32433,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,32433,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,32433,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,32434,0)
 ;;=D56.8^^119^1564^186
 ;;^UTILITY(U,$J,358.3,32434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32434,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,32434,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,32434,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,32435,0)
 ;;=C82.89^^119^1564^76
 ;;^UTILITY(U,$J,358.3,32435,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32435,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,32435,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,32435,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,32436,0)
 ;;=D51.8^^119^1564^193
 ;;^UTILITY(U,$J,358.3,32436,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32436,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,32436,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,32436,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,32437,0)
 ;;=I80.9^^119^1564^178
 ;;^UTILITY(U,$J,358.3,32437,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32437,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,32437,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,32437,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,32438,0)
 ;;=D45.^^119^1564^179
 ;;^UTILITY(U,$J,358.3,32438,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32438,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,32438,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,32438,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,32439,0)
 ;;=C77.3^^119^1564^109
 ;;^UTILITY(U,$J,358.3,32439,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32439,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,32439,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,32439,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,32440,0)
 ;;=C77.2^^119^1564^125
 ;;^UTILITY(U,$J,358.3,32440,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32440,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,32440,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,32440,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,32441,0)
 ;;=C77.1^^119^1564^126
 ;;^UTILITY(U,$J,358.3,32441,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32441,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,32441,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,32441,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,32442,0)
 ;;=C77.0^^119^1564^142
 ;;^UTILITY(U,$J,358.3,32442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32442,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,32442,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,32442,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,32443,0)
 ;;=C77.8^^119^1564^143
 ;;^UTILITY(U,$J,358.3,32443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32443,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,32443,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,32443,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,32444,0)
 ;;=C79.51^^119^1564^113
 ;;^UTILITY(U,$J,358.3,32444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32444,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,32444,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,32444,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,32445,0)
 ;;=C79.52^^119^1564^112
 ;;^UTILITY(U,$J,358.3,32445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32445,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,32445,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,32445,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,32446,0)
 ;;=C79.31^^119^1564^114
 ;;^UTILITY(U,$J,358.3,32446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32446,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,32446,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,32446,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,32447,0)
 ;;=C79.72^^119^1564^129
 ;;^UTILITY(U,$J,358.3,32447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32447,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,32447,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,32447,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,32448,0)
 ;;=C78.02^^119^1564^133
 ;;^UTILITY(U,$J,358.3,32448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32448,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,32448,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,32448,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,32449,0)
 ;;=C78.7^^119^1564^138
 ;;^UTILITY(U,$J,358.3,32449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32449,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,32449,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,32449,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,32450,0)
 ;;=C79.71^^119^1564^151
